BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33004046)

  • 21. Functional imaging-guided carbon ion irradiation with simultaneous integrated boost for localized prostate cancer: study protocol for a phase II randomized controlled clinical trial.
    Hu W; Li P; Hong Z; Guo X; Pei Y; Zhang Z; Zhang Q
    Trials; 2022 Nov; 23(1):934. PubMed ID: 36348363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
    Shirai K; Kawashima M; Saitoh JI; Abe T; Fukata K; Shigeta Y; Irie D; Shiba S; Okano N; Ohno T; Nakano T
    PLoS One; 2017; 12(4):e0175589. PubMed ID: 28399182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
    Habl G; Uhl M; Katayama S; Kessel KA; Hatiboglu G; Hadaschik B; Edler L; Tichy D; Ellerbrock M; Haberer T; Wolf MB; Schlemmer HP; Debus J; Herfarth K
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):435-443. PubMed ID: 27084659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase 1/2 Study of Carbon Ion Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
    Okonogi N; Wakatsuki M; Kato S; Karasawa K; Miyasaka Y; Murata H; Nakano T; Kamada T; Shozu M;
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):631-639. PubMed ID: 30825494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
    Dreher C; Habermehl D; Jäkel O; Combs SE
    Radiat Oncol; 2017 Dec; 12(1):203. PubMed ID: 29282139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton and carbon ion radiation therapy for locally advanced pancreatic cancer: A phase I dose escalation study.
    Yu Z; Hong Z; Zhang Q; Lin LC; Shahnazi K; Wu X; Lu J; Jiang G; Wang Z
    Pancreatology; 2020 Apr; 20(3):470-476. PubMed ID: 32033896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
    Hiroshima Y; Fukumitsu N; Saito T; Numajiri H; Murofushi KN; Ohnishi K; Nonaka T; Ishikawa H; Okumura T; Sakurai H
    Radiother Oncol; 2019 Jul; 136():37-43. PubMed ID: 31015127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon-ion radiotherapy for locoregional recurrence after primary surgery for pancreatic cancer.
    Kawashiro S; Yamada S; Isozaki Y; Nemoto K; Tsuji H; Kamada T
    Radiother Oncol; 2018 Oct; 129(1):101-104. PubMed ID: 29463433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumors.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2018 May; 109(5):1562-1569. PubMed ID: 29498145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum.
    Shinoto M; Yamada S; Okamoto M; Shioyama Y; Ohno T; Nakano T; Nemoto K; Isozaki Y; Kawashiro S; Tsuji H; Kamada T
    Radiother Oncol; 2019 Mar; 132():236-240. PubMed ID: 30360998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbon ion radiotherapy in pancreatic cancer: A review of clinical data.
    Liermann J; Shinoto M; Syed M; Debus J; Herfarth K; Naumann P
    Radiother Oncol; 2020 Jun; 147():145-150. PubMed ID: 32416281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer.
    Okusaka T; Okada S; Sato T; Wakasugi H; Saisho H; Furuse J; Ishikawa O; Matsuno S; Yokoyama S
    Hepatogastroenterology; 1998; 45(21):867-72. PubMed ID: 9684148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
    Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
    Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-dimensional treatment planning in layer-stacking boost irradiation for carbon-ion pancreatic therapy.
    Mori S; Shinoto M; Yamada S
    Radiother Oncol; 2014 May; 111(2):258-63. PubMed ID: 24746568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
    Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
    BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of octogenarian pancreatic cancer patients treated with carbon ion radiotherapy.
    Bhattacharyya T; Shinoto M; Takiyama H; Nitta Y; Koto M; Imai R; Ikawa H; Nomoto A; Tsuji H; Yamada S
    Pancreatology; 2022 Apr; 22(3):381-386. PubMed ID: 35317974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
    Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
    BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.
    Comito T; Cozzi L; Clerici E; Franzese C; Tozzi A; Iftode C; Navarria P; D'Agostino G; Rimassa L; Carnaghi C; Personeni N; Tronconi MC; De Rose F; Franceschini D; Ascolese AM; Fogliata A; Tomatis S; Santoro A; Zerbi A; Scorsetti M
    Technol Cancer Res Treat; 2017 Jun; 16(3):295-301. PubMed ID: 27311310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.